Lithium Ion

Lithium Ion

SCHEMBL8065172

C/C(=C\c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc(Cl)cc1C(=O)[O-].[Li+]

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMPRSS4 Q9NRS4 5/20 0.42
P2RX1 P51575 2/20 0.42
P2RX4 Q99571 2/20 0.42
P2RX7 Q99572 2/20 0.42
DHODH Q02127 2/20 0.42
TRPM8 Q7Z2W7 1/20 0.42
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
GRIK1 P39086 1/20 0.40
CCR9 P51686 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SERPINE1 P05121 1/20 0.39
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
PTGS1 P23219 1/20 0.38
HSPH1 Q92598 1/20 0.38
MPO P05164 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL8063209 0.91 GRIK1 (0.47) TMPRSS4P2RX1P2RX4P2RX7DHODH
SCHEMBL8064143 0.89 KDM4E (0.53) TMPRSS4P2RX1P2RX4P2RX7DHODH
SCHEMBL8064144 0.89 KDM4E (0.53) TMPRSS4P2RX1P2RX4P2RX7DHODH
SCHEMBL8065170 0.88 KDM4E (0.52) TMPRSS4P2RX1P2RX4P2RX7DHODH
SCHEMBL8065176 0.88 KDM4E (0.52) TMPRSS4P2RX1P2RX4P2RX7DHODH
Lithium Ion SCHEMBL8048870 0.84 TRPM8 (0.57) DHODHTRPM8KDM4ERAB9APTGS1
SCHEMBL8058427 0.82 GRIK1 (0.61) DHODHTRPM8PPARGPPARDNR1H4
SCHEMBL8058422 0.82 GRIK1 (0.61) DHODHTRPM8PPARGPPARDNR1H4
SCHEMBL8060374 0.82 TRPM8 (0.57) DHODHTRPM8KDM4ERAB9APTGS1
SCHEMBL8063210 0.81 GRIK1 (0.60) DHODHTRPM8PPARGPPARDNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US claimed
EP-1003712-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-05-31 EP claimed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US claimed
WO-1999007669-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 1999-02-18 WO claimed
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
EP-1003712-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-05-31 EP disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed
WO-1999007669-A1 ANTHRANILIC ACID ANALOGS AMERICAN HOME PRODUCTS CORPORATION (US) 1999-02-18 WO disclosed